![]() |
市場調查報告書
商品編碼
1459338
全球西伯利亞人參市場 - 2024-2031Global Siberian Ginseng Market - 2024-2031 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
概述
2023年,全球西伯利亞人參市場規模達2,125萬美元,預估至2031年將達到2,137萬美元,2024-2031年預測期間複合CAGR為7.1%。
消費者擴大轉向西伯利亞人參等植物補充劑,因為它們據稱具有健康益處,從而推動了市場的成長。市場參與者專注於產品創新和差異化,以在競爭激烈的市場中脫穎而出。這包括開發新配方、組合產品和輸送系統,以提高功效並吸引不同的消費者偏好。
例如,2024年3月13日,韓國人參公司(KGC)旗下品牌正官莊擴大了紅參零食的選擇範圍,以在復古產品日益流行的背景下吸引年輕消費者的興趣。高麗參因其增強免疫力的特性和幫助恢復能量的能力而受到認可,高麗參種植在優質土壤中,確保了卓越的品質。
西伯利亞人參在北美運動營養市場越來越受歡迎。運動員和健身愛好者正在將西伯利亞人參補充劑納入他們的治療方案中,以增強耐力、體力和恢復能力,從而推動該領域的市場成長。市場參與者正在響應這一趨勢,推出採用有機和永續來源成分製成的西伯利亞人參補充劑,吸引尋求天然和環保選擇的消費者。
動力學
對草藥補充劑的需求不斷增加
對草藥補充劑的需求不斷成長有助於整個西伯利亞人參市場的擴大。隨著越來越多的消費者尋求傳統藥物的天然替代品,草藥補充劑(包括含有西伯利亞人參的補充劑)的市場正在經歷成長。對草藥補充劑的需求涉及各個人群,包括注重健康的個人和尋求替代醫療保健選擇的老齡化人群。這種廣泛的消費者基礎推動了市場的成長。
由於擔心潛在的副作用和對整體健康方法的渴望,消費者更喜歡自然療法而不是合成藥物。西伯利亞人蔘符合這種偏好,吸引了尋求自然解決健康問題的消費者。對草藥補充劑的需求不斷成長,鼓勵市場參與者創新並擴大其產品組合。
擴大製藥應用
將西伯利亞人參納入藥物配方使其市場用途多樣化,超越傳統草藥補充劑。隨著製藥公司探索其潛在的治療特性,西伯利亞人參作為處方藥和非處方藥的關鍵成分而受到關注。患者更傾向於信任醫療保健專業人士推薦的產品,從而提高了西伯利亞人參藥物的接受度和採用率。
醫藥應用的擴展擴大了對西伯利亞人參的需求,因為西伯利亞人參因其潛在的健康益處而受到醫療保健專業人員和患者的追捧,並刺激了市場成長。對西伯利亞人參製藥潛力的探索刺激了市場內的研發投資。製藥公司投資臨床試驗、功效研究和配方開發,以驗證其藥用特性並創造可上市的產品。
高監管挑戰
對西伯利亞人參產品銷售和分銷的嚴格監管要求可能會造成巨大的市場進入障礙。遵守不同地區的不同法規會增加產品上市的複雜性和成本,阻止潛在的市場進入者。註冊、許可和遵守品質標準等監管障礙限制了西伯利亞人參產品在某些市場的供應。
相關成本給製造商帶來了負擔,導致產品價格上漲,降低了消費者的負擔能力,並可能抑制市場需求。冗長的法規核准流程可能會延遲新西伯利亞人蔘產品推向市場的時間。市場擴張的緩慢步伐阻礙了西伯利亞人參市場的成長潛力,特別是在監管制度嚴格或核准程序複雜的地區。
例如,2023 年 8 月 8 日,美國食品藥物管理局 (FDA) 繼續實施進口警報,作為其維護進口食品嚴格食品安全法規的一部分。該機構定期審查和調整這些警報,以確保遵守限制市場成長的監管標準。
Overview
Global Siberian Ginseng Market reached US$ 21.25 million in 2023 and is expected to reach US$ 21.37 million by 2031, growing with a CAGR of 7.1% during the forecast period 2024-2031.
Consumers are increasingly turning to botanical supplements like Siberian ginseng for their purported health benefits, driving the market growth. Market players are focusing on product innovation and differentiation to stand out in a competitive market. This includes the development of new formulations, combination products, and delivery systems to enhance efficacy and appeal to diverse consumer preferences.
For instance, on March 13, 2024, Cheong Kwan Jang, a brand owned by Korea Ginseng Corporation (KGC), extended its selection of red ginseng snacks to capture the interest of younger consumers amidst a growing trend for retro products. It is recognized for its immune-boosting properties and capacity to aid in energy revitalization, Korean ginseng is cultivated in premium soil, ensuring exceptional quality.
Siberian ginseng is gaining popularity in the sports nutrition market in North America. Athletes and fitness enthusiasts are incorporating Siberian ginseng supplements into their regimens to enhance endurance, stamina, and recovery, driving market growth in this segment. Market players are responding to this trend by offering Siberian Ginseng supplements made with organic and sustainably sourced ingredients, appealing to consumers seeking natural and environmentally friendly options.
Dynamics
Increasing Demand for Herbal Supplements
The rising demand for herbal supplements contributes to the expansion of the overall Siberian Ginseng market. As more consumers seek natural alternatives to conventional medications, the market for herbal supplements, including those containing Siberian ginseng, experiences growth. The demand for herbal supplements cuts across various demographic segments, including health-conscious individuals, and aging populations seeking alternative healthcare options. This broad consumer base drives market growth.
Consumers prefer natural remedies over synthetic medications due to concerns about potential side effects and a desire for holistic health approaches. Siberian ginseng aligns with this preference and attracts consumers looking for natural solutions to health issues. The growing demand for herbal supplements encourages market players to innovate and expand their product portfolios.
Expanding Pharmaceutical Applications
The incorporation of Siberian Ginseng into pharmaceutical formulations diversifies its market usage beyond traditional herbal supplements. As pharmaceutical companies explore its potential therapeutic properties, Siberian Ginseng gains traction as a key ingredient in prescription and over-the-counter medications. Patients are more inclined to trust products recommended by healthcare professionals, thereby boosting the acceptance and adoption of Siberian Ginseng-based pharmaceuticals.
The expansion of pharmaceutical applications broadens the demand for Siberian Ginseng, as it becomes sought after by healthcare professionals and patients for its potential health benefits, and stimulates market growth. The exploration of Siberian Ginseng's pharmaceutical potential spurs investments in research and development within the market. Pharmaceutical companies invest in clinical trials, efficacy studies, and formulation development to validate its medicinal properties and create market-ready products.
High Regulatory Challenges
Stringent regulatory requirements for the sale and distribution of Siberian Ginseng products can create significant barriers to market entry. Compliance with diverse regulations across different regions increases the complexity and cost of bringing products to market, deterring potential market entrants. Regulatory hurdles, such as registration, licensing, and compliance with quality standards, limit the availability of Siberian Ginseng products in certain markets.
The associated costs pose a burden on manufacturers and lead to higher product prices, reducing consumer affordability and potentially dampening market demand. Lengthy regulatory approval processes can delay the introduction of new Siberian Ginseng products to the market. This sluggish pace of market expansion impedes the growth potential of the Siberian Ginseng market, particularly in regions with stringent regulatory regimes or complex approval procedures.
For instance, on August 8, 2023, The Food and Drug Administration (FDA) maintained its implementation of import alerts as part of its efforts to uphold stringent food safety regulations for imported food products. These alerts are regularly reviewed and adjusted by the agency to ensure compliance with regulatory standards, which factors are restraining the market growth.
The global Siberian ginseng market is segmented based on product type, source, application, and region.
Ease of Use and Versatility and Longer Shelf Life of Powdered Extracts
Powdered extracts hold the largest share of the global Siberian ginseng market. Powdered extracts offer convenience and versatility, making them popular among consumers. They can be easily mixed into various formulations, catering to diverse consumer preferences and usage scenarios. Powdered extracts are concentrated forms of Siberian ginseng, containing higher levels of active compounds compared to other forms, enhancing their efficacy and perceived value, and boosting demand in the market.
Powdered extracts generally have a longer shelf life, making them more suitable for storage and distribution. This extended shelf life reduces the risk of product spoilage and wastage, contributing to their popularity in the market. Powdered extracts of Siberian ginseng are used in various industries. Their broad application range expands market opportunities and contributes to their dominance in the global Siberian ginseng market.
Rising Consumer Demand and Innovations in North America
North America dominates the global Siberian ginseng market. The region boasts a substantial consumer base interested in natural health remedies and supplements. This sizable market demand drives significant sales of Siberian ginseng products. North American companies are often at the forefront of marketing and branding efforts. They employ sophisticated strategies to promote Siberian ginseng products, creating consumer awareness and driving sales both domestically and internationally.
North America is an innovation hub for dietary supplements and functional foods. Companies in the region are continually developing new formulations and product variations, driving market growth and maintaining competitiveness on a global scale. North American research institutions and companies actively contribute to the scientific understanding of Siberian Ginseng and its potential health benefits. This research fuels product development and innovation, driving market expansion and dominance.
The pandemic disrupted global supply chains, affecting the sourcing and distribution of Siberian Ginseng raw materials and finished products. Lockdowns, travel restrictions, and trade disruptions hindered the movement of goods, leading to delays in production and supply chain bottlenecks, thereby impacting the market. Market players faced compliance challenges and increased scrutiny, necessitating adjustments to their operations and marketing strategies to ensure regulatory compliance.
The pandemic underscored the importance of maintaining health and wellness, leading to a surge in demand for dietary supplements and herbal remedies. This heightened awareness of preventive healthcare measures contributed to increased sales of Siberian Ginseng products, particularly those marketed for immune support and stress relief. With lockdowns and social distancing measures in place, there was a significant shift towards online shopping.
The conflict disrupted supply chains as both Russia and Ukraine are significant producers of Siberian Ginseng. Disruptions in transportation routes, trade restrictions, and logistical challenges hindered the movement of raw materials and finished products, impacting the market's supply chain. Uncertainty surrounding supply disruptions and geopolitical developments led to fluctuations in prices, affecting market dynamics and profitability for market players.
The Russia-Ukraine war created market uncertainty, prompting caution among buyers and investors. Concerns about the stability of supply, geopolitical risks, and potential market disruptions led to hesitancy in purchasing decisions, impacting market sentiment and activity. Market participants sought to diversify their sourcing strategies to mitigate risks associated with the conflict.
The major global players in the Siberian ginseng market include Speedrange Ltd., Lamberts Healthcare Ltd., OstroVit Sp. z o.o., MyFitFuel, Amway India Enterprises Pvt. Ltd., SimplySupplements, Nature's Way Products, Inc., NOW Health Group, Inc., Harmonic Arts, and Natural Factors Canada.
The global Siberian ginseng market report would provide approximately 62 tables, 54 figures, and 213 Pages.
LIST NOT EXHAUSTIVE